Leading private capital deals today include Blackstone's $300 million investment in DDN and a B Capital-led $275 million ...

Venture capital firm Vensana Capital, headquartered in Minneapolis, has closed a $425 million fund to further fuel medtech startups, some of which are in Twin Cities. Founded in 2019, Vensana invests ...

Those other times when things went wrong — we’re talking four Super Bowl losses plus 1998, 2000, 2009 and 2017 — weren’t ...

Marks & Clerk says there is a lack of clarity over how IP protection safeguards the innovations underpinning the UK medtech ...

It’s incredibly rewarding to build in the medtech space, but some data suggests the average medical device requires $31 ...

Med Tech & Diagnostics Analysts Matson and Saxon, along with Dr. Kevin Cronin, Assistant Professor of Orthopaedic Surgery at the University ...

This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends ...

Leadership in Medtech issue features former Edwards Lifesciences CEO Mike Mussallem and FDA CDRH Director Dr. Michelle Tarver ...

"This is going to be a broad approach. ... There's a big list to go after, but we're committed to make a difference," ...

Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the ...

FlowBeams, creator of the BoldJet needle-free injection showcased itsbreakthrough medtech technology at CES 2025.The company’s innovative needle-free injection ...

Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...